New Experimental Therapeutics of Virginia - NEXT Oncology

Fairfax, Virginia 22031

0 studies enrolling now · 3 studies all time

What they study most

Adenocarcinoma, Antineoplastic Agents, Brain Metastases, Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, EGFR Activating Mutation, EGFR Atypical Mutations, Including G719X and L861Q, EGFR Exon 20 Insertion Mutation, EGFR Exon 20 Mutation

Studies at this site

• A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies — Running, not enrolling
• A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors — Running, not enrolling
• (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations — Stopped early